You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Healthy Atopic adults

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atopic Dermatitis, Healthy Volunteers Trial (Tezepelumab, Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • Healthy Volunteers
  • (no location specified)
Sep 8, 2022

Atopic Dermatitis Trial in Anaheim (FB825 or Placebo in subcutaneous route, FB825 in intravenous route)

Active, not recruiting
  • Atopic Dermatitis
  • FB825 or Placebo in subcutaneous route
  • FB825 in intravenous route
  • Anaheim, California
    Phase I center
Jul 11, 2023

Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis

Completed
  • Healthy Adults
  • +4 more
  • Gas sensor
  • Sweat Sensor
  • Chicago, Illinois
    Northwestern University
Apr 19, 2022

Atopic Dermatitis, Eczema Trial (Lebrikizumab)

Not yet recruiting
  • Atopic Dermatitis
  • Eczema
  • Lebrikizumab
  • (no location specified)
Aug 7, 2023

Atopic Dermatitis Trial in Tel Aviv (Fecal Microbial Transplantation, fecal transplantation)

Recruiting
  • Atopic Dermatitis
  • Fecal Microbial Transplantation
  • placebo fecal transplantation
  • Tel Aviv, Israel
  • +1 more
Jul 21, 2022

Complementary and Alternative Medicine in Children and Atopic

Not yet recruiting
  • Atopic Dermatitis
  • Self-administered questionnaire
  • Nancy, France
    University Hospital of Nancy
Apr 18, 2023

Healthy, Atopic Dermatitis Trial in Daytona Beach (LY3872386, Prednisone, Placebo)

Not yet recruiting
  • Healthy
  • Atopic Dermatitis
  • Daytona Beach, Florida
    Fortrea Clinical Research Unit
Nov 1, 2023

Scratching Validation Study

Recruiting
  • Atopic Dermatitis
  • Actigraphy Device
  • Maplewood, Missouri
    Clayton Sleep Institute
Aug 22, 2022

Atopic Dermatitis Trial in Bexley (Part 1 ADX-629 (Open-label))

Not yet recruiting
  • Atopic Dermatitis
  • Part 1 ADX-629 (Open-label)
  • Bexley, Ohio
    Bexley Dermatology Research
Feb 6, 2023

Atopic Dermatitis Trial in East Syracuse, Arlington (ruxolitinib cream)

Recruiting
  • Atopic Dermatitis
  • ruxolitinib cream
  • East Syracuse, New York
  • +1 more
Jan 13, 2023

Atopic Dermatitis Trial (LEO 138559, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • LEO 138559
  • Placebo
  • (no location specified)
Jun 20, 2023

Atopic Dermatitis Trial (VC005, VC005 Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • (no location specified)
Aug 18, 2023

Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis, AD Trial in United States (IMG-007)

Recruiting
  • Atopic Dermatitis
  • +2 more
  • Miami, Florida
  • +3 more
Aug 9, 2023

Skin Microbes in Healthy People and in People With Skin

Recruiting
  • Atopic Dermatitis
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Lipikar Baume AP+M on Quality of Life and Pain of Dryness or

    Recruiting
    • Atopic Dermatitis
    • Skin Diseases
      • Zagreb, Croatia
      • +6 more
      Mar 11, 2023

      Atopic Dermatitis Trial in Glendale (UCB1381, Placebo)

      Recruiting
      • Atopic Dermatitis
      • UCB1381
      • Placebo
      • Glendale, California
        Up0110 101
      Jan 20, 2023

      Healthy, Dermatitis, Atopic Trial in Glendale (LY3844583, Placebo)

      Recruiting
      • Healthy
      • Dermatitis, Atopic
      • Glendale, California
        Parexel Early Phase Unit at Glendale
      Aug 17, 2022

      Dermatitis, Atopic Trial in China (611 Q2W, 611 Q4W, Matching )

      Not yet recruiting
      • Dermatitis, Atopic
      • 611 Q2W
      • +2 more
      • Beijing, Beijing, China
      • +4 more
      Sep 15, 2022

      Mild to Moderate Atopic Dermatitis Trial (IN-A002 Ointment 0.3% or IN-A002 Placebo Ointment, IN-A002 Ointment 0.5% or IN-A002

      Not yet recruiting
      • Mild to Moderate Atopic Dermatitis
      • IN-A002 Ointment 0.3% or IN-A002 Placebo Ointment
      • +7 more
      • (no location specified)
      Feb 6, 2023

      Atopic Healthy Subjects, Adult Subjects With Mild Allergic Diseases Trial in Korea, Republic of (YH35324, Placebo, Omalizumab)

      Completed
      • Atopic Healthy Subjects
      • Adult Subjects With Mild Allergic Diseases
      • Suwon-si, Gyeonggi-do, Korea, Republic of
      • +3 more
      Jan 26, 2023

      Atopic Dermatitis Trial in Woolloongabba, Adelaide (FMX114, Vehicle)

      Completed
      • Atopic Dermatitis
      • Miami, Florida
      • +6 more
      Aug 25, 2022

      Atopic Dermatitis Trial in Glendale (NM26-2198, Placebo)

      Recruiting
      • Atopic Dermatitis
      • NM26-2198
      • Placebo
      • Glendale, California
        California Clinical Trials Medical Group (CCTMG) managed by Pare
      May 15, 2023

      Atopic Dermatitis Trial in Taipei (FB825)

      Completed
      • Atopic Dermatitis
      • FB825
      • Taipei, Taiwan
        National Taiwan University Hospital
      Mar 31, 2022

      Atopic Dermatitis Trial in Shanghai (0.1% QY211 Gel or , 0.3% QY211 Gel or , 0.8% QY211 Gel or )

      Recruiting
      • Atopic Dermatitis
      • 0.1% QY211 Gel or placebo
      • +3 more
      • Shanghai, Shanghai, China
        Huashan Hospital Affiliated to Fudan University
      Apr 24, 2023

      Moderate to Severe Atopic Dermatitis Trial (SHR1819, Placebo)

      Not yet recruiting
      • Moderate to Severe Atopic Dermatitis
      • (no location specified)
      Sep 21, 2022